Ubs Oconnor LLC Geron Corp Transaction History
Ubs Oconnor LLC
- $2.23 Billion
- Q2 2025
A detailed history of Ubs Oconnor LLC transactions in Geron Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 53,000 shares of GERN stock, worth $67,310. This represents 0.01% of its overall portfolio holdings.
Number of Shares
53,000Holding current value
$67,310% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GERN
# of Institutions
282Shares Held
509MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$76.7 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$59.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$54.6 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$45.2 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$34.6 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $480M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...